Sexual Health / legal status / Last reviewed 2026-04-04

Triptorelin Legal Status: Approval, Research Use, and Regulatory Notes

FDA-approved prescription medication (Trelstar). Available by prescription only. Not a controlled substance.

Read the full Triptorelin guide Browse answer pages

Direct Answer

Triptorelin (Trelstar) is FDA-approved for prostate cancer androgen deprivation and gender-affirming hormone therapy, with multiple Phase 3 RCTs supporting both indications. As a GnRH agonist, it produces reliable castrate-level testosterone suppression with a well-characterized adverse effect profile. For research into GnRH agonist pharmacology or testosterone suppression, it is a validated reference compound.

Evidence grade
Level A
Research status
FDA Approved
Category
Sexual Health
Best for
Prostate cancer androgen deprivation, gender-affirming hormone therapy, GnRH agonist pharmacology

Legal and Regulatory Status

FDA-approved prescription medication (Trelstar). Available by prescription only. Not a controlled substance.

Approval Stage

Triptorelin is listed as FDA Approved. Approved uses, if any, are indication-specific and do not automatically apply to other claims.

Compliance Notes

Evidence Page

For the complete evidence review, see the main Triptorelin guide linked below.

Evidence Snapshot

Evidence gradeLevel A
Research statusFDA Approved
Best supported outcomesProstate Cancer Control (Level A), Endometriosis Symptom Relief (Level A), and Central Precocious Puberty Arrest (Level A)
Primary citation count3
Last reviewed2026-04-04

Related Guides

How to Cite This Page

ExaminePeptides. "Triptorelin Legal Status: Approval, Research Use, and Regulatory Notes." Last reviewed 2026-04-04. https://examinepeptides.com/answers/triptorelin-legal-status/

This static answer page is built for fast indexing and direct citation. It summarizes the matching full evidence review and links back to primary sources where the source database includes them.